Eléments de l'association

	Paul Henning	1
	Atypical Hemolytic Uremic Syndrome (drug therapy)	1
	Paul Henning *Sauf* Atypical Hemolytic Uremic Syndrome (drug therapy)"	0
	Atypical Hemolytic Uremic Syndrome (drug therapy) *Sauf* Paul Henning"	0
	Paul Henning Et Atypical Hemolytic Uremic Syndrome (drug therapy)	1
	Paul Henning Ou Atypical Hemolytic Uremic Syndrome (drug therapy)	1
	*Corpus*	3114

List of bibliographic references

Number of relevant bibliographic references: 1.

Ident.	Authors (with country if any)	Title
000712	Larry A. Greenbaum [États-Unis] ; Marc Fila [France] ; Gianluigi Ardissino [Italie] ; Samhar I. Al-Akash [États-Unis] ; Jonathan Evans [Royaume-Uni] ; Paul Henning [Australie] ; Kenneth V. Lieberman [États-Unis] ; Silvio Maringhini [Italie] ; Lars Pape [Allemagne] ; Lesley Rees [Royaume-Uni] ; Nicole C A J. Van De Kar [Pays-Bas] ; Johan Vande Walle [Belgique] ; Masayo Ogawa [États-Unis] ; Camille L. Bedrosian [États-Unis] ; Christoph Licht [Canada]	Eculizumab is a safe and effective treatment in pediatric patients with atypical hemolytic uremic syndrome.

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Tue Dec 5 10:43:12 2017. Site generation: Tue Mar 5 14:07:20 2024